Alfadolone acetate

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 528404

CAS#: 23930-37-2

Description: Alfadolone acetate (also known as GR-2, 1574, R-140, V-140, and alphadolone acetate) is a gamma-aminobutyric acid (GABA) receptor agonist potentially for the treatment of cancer related pain.

Chemical Structure

img
Alfadolone acetate
CAS# 23930-37-2
Instruction

Theoretical Analysis

MedKoo Cat#: 528404
Name: Alfadolone acetate
CAS#: 23930-37-2
Chemical Formula: C23H34O5
Exact Mass: 390.24
Molecular Weight: 390.520
Elemental Analysis: C, 70.74; H, 8.78; O, 20.48

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Alfadolone acetate; GR-2; GR 2; GR2; 1574; R-140; R140; R 140; V-140; V 140; V140; alphadolone acetate

IUPAC/Chemical Name: 2-((3R,5S,8S,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-11-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate

InChi Key: QRJOQYLXZPQQMX-FWROMSNXSA-N

InChi Code: InChI=1S/C23H34O5/c1-13(24)28-12-20(27)18-7-6-17-16-5-4-14-10-15(25)8-9-22(14,2)21(16)19(26)11-23(17,18)3/h14-18,21,25H,4-12H2,1-3H3/t14-,15+,16-,17-,18+,21+,22-,23-/m0/s1

SMILES Code: C[C@@]1(C2)[C@@H](C(COC(C)=O)=O)CC[C@@]1([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C2=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 390.52 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Nadeson R, Goodchild CS. Antinociceptive properties of neurosteroids III: experiments with alphadolone given intravenously, intraperitoneally, and intragastrically. Br J Anaesth. 2001 May;86(5):704-8. PubMed PMID: 11575348.

2: Nadeson R, Goodchild CS. Antinociceptive properties of neurosteroids II. Experiments with Saffan and its components alphaxalone and alphadolone to reveal separation of anaesthetic and antinociceptive effects and the involvement of spinal cord GABA(A) receptors. Pain. 2000 Oct;88(1):31-9. PubMed PMID: 11098097.

3: Benoit E. Effects of intravenous anaesthetics on nerve axons. Eur J Anaesthesiol. 1995 Jan;12(1):59-70. PubMed PMID: 7705328.

4: Nádvorník P, Kolarík J, Drlicková V. Contribution of pregnan steroid Althesin to the pathophysiology of epilepsy. Acta Univ Palacki Olomuc Fac Med. 1990;128:17-21. PubMed PMID: 2149796.

5: Brown JN, Thorne PR, Nuttall AL. Blood pressure and other physiological responses in awake and anesthetized guinea pigs. Lab Anim Sci. 1989 Mar;39(2):142-8. PubMed PMID: 2709804.

6: Cervantes M, Ruelas R, Sánchez R, Alvarez-Reséndiz G. Brain injury following cardiorespiratory arrest in cats. Effects of alphaxalone-alphadolone. Bol Estud Med Biol. 1989 Jan-Jun;37(1-2):17-27. PubMed PMID: 2803470.

7: Benoit E, Carratù MR, Mitolo-Chieppa D. Mechanism of action of a structural analog of alphaxalone on myelinated nerve fibre. Eur J Pharmacol. 1988 Dec 6;158(1-2):1-9. PubMed PMID: 2851452.

8: Suzuki T, Tomioka M, Uchida MK. Inhibitory effects of steroidal anesthetics on histamine release from rat mast cells stimulated by concanavalin A, compound 48/80 and A23187. Gen Pharmacol. 1988;19(3):435-40. PubMed PMID: 2458297.

9: Emanuele MA, Tentler J, Kirsteins L, Reda D, Emanuele NV, Lawrence AM. Anaesthesia with alphaxalone plus alphadolone acetate decreases serum concentrations of LH in castrated rats. J Endocrinol. 1987 Nov;115(2):221-3. PubMed PMID: 3437247.

10: Perrot D, Pugeat M, Bonneton A, Mounier-Kuhn A, Motin J, Forest MG. Althesin interaction with human plasma steroid binding globulins. Eur J Clin Pharmacol. 1985;29(2):181-5. PubMed PMID: 4076318.

11: Ravlo O, Carl P, Crawford ME, Bach V, Kruse L. [Total intravenous anesthesia with etomidate and alphadolone acetate infusion]. Ugeskr Laeger. 1984 Dec 3;146(49):3830-3. Danish. PubMed PMID: 6393513.

12: Holmes GL, Weber DA, Kloczko N, Zimmerman AW. Relationship of endocrine function to inhibition of kindling. Brain Res. 1984 Sep;318(1):55-9. PubMed PMID: 6488054.

13: Dyer RG, Mansfield S. Anaesthesia with alphaxalone plus alphadolone acetate blocks the oestrogen-stimulated LH surge and impairs pulsatile LH secretion in ovariectomized female rats. J Endocrinol. 1984 Jul;102(1):27-31. PubMed PMID: 6736851.

14: Sear JW, Sanders RS. Intra-patient comparison of the kinetics of alphaxalone and alphadolone in man. Eur J Anaesthesiol. 1984 Jun;1(2):113-22. PubMed PMID: 6536512.

15: McQueen JK, Martin MJ, Harmar AJ. Local changes in cerebral 2-deoxyglucose uptake during alphaxalone anaesthesia with special reference to the habenulo-interpeduncular system. Brain Res. 1984 May 21;300(1):19-26. PubMed PMID: 6203604.

16: McQueen JK, Martin MJ, Fink G. Comparison of the effects of Althesin and sodium pentobarbitone on the regional uptake of 2-deoxyglucose by the brain and pituitary gland of the rat: selective effects on pars intermedia. Neuroendocrinology. 1984 Mar;38(3):237-42. PubMed PMID: 6717749.

17: Shigematsu A, Takahashi S, Tanaka T, Nakamura S. Spectral studies on the effect of a new steroidal anesthetic agent alphadione on rat hepatic microsomes. J UOEH. 1983 Sep 1;5(3):343-9. PubMed PMID: 6679642.

18: Tachon P, Descotes J, Laschi-Loquerie A, Guillot JP, Evreux JC. Assessment of the allergenic potential of althesin and its constituents. Br J Anaesth. 1983 Aug;55(8):715-7. PubMed PMID: 6882610.

19: McIlhany M, Rapport R, Dunn R, Namazie M, Delilikan A. Althesin in the management of head injuries: a preliminary report. Neurosurgery. 1983 Jan;12(1):77-9. PubMed PMID: 6828225.

20: Farkas Z. Acoustic reflex and general anaesthesia. Scand Audiol Suppl. 1983;17:43-6. PubMed PMID: 6577558.